Immunotherapy Industry, October 2014 Market Reports from Top Publishers

You might be interested in: cancer, therapeutics, medical equipment, more »


 
1-10 of 39 reports for Immunotherapy

Opexa Therapeutics, Inc. (Symbol:OPXA) SWOT Analysis, Strategy, Revenues and Profits

Opexa Therapeutics, Inc. (Symbol:OPXA) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

... Which is a personalized t-cell immunotherapy in a phase iib clinical development program for the treatment of secondary progressive multiple sclerosis. The company specializes in flow cytometry ...

Compugen Ltd. (Symbol:CGEN) SWOT Analysis, Strategy, Revenues and Profits

Compugen Ltd. (Symbol:CGEN) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

... Discloses achievement of milestone in cancer immunotherapy collaboration with bayerthis comprehensive swot profile of compugen ltd. Provides you an in-depth strategic analysis of the company ...

Sorrento Therapeutics, Inc. (Symbol:SRNE) SWOT Analysis, Strategy, Revenues and Profits

Sorrento Therapeutics, Inc. (Symbol:SRNE) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

... Is headquartered in san diego, california, the us.Sorrento therapeutics, inc. Key recent developmentsaug 26, 2014: sorrento awarded nih grant to advance immunotherapy targeting idiopathic pulmonary ...

Genitope Corporation (GTOP) - Strategic SWOT Analysis Review

Genitope Corporation (GTOP) - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2014
  • by Global Data

... Amplification helps development of personalized active immunotherapies. Genitope help patients who are diagnosed with b-cell malignancies. The company is headquartered in california, the us ...

Dendreon Corporation (Symbol:DNDN) SWOT Analysis, Strategy, Revenues and Profits

Dendreon Corporation (Symbol:DNDN) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • September 2014
  • by Global Data

... Active cellular immunotherapies and immunotherapy targets such as dn24-02, carbonic anhydrase ix, carcinoembryonic antigen, and small molecules such as trpm8. It conducts manufacturing in atlanta ...

Cancer Immunotherapy: immune checkpoint inhibitors, cancer vaccines, and adoptive T-cell therapies

Cancer Immunotherapy: immune checkpoint inhibitors, cancer vaccines, and adoptive T-cell therapies

  • $ 2 495
  • Industry report
  • September 2014
  • by CHI Insight Pharma Reports

... The future of adoptive immunotherapy for cancer outlook for cancer immunotherapy chapter 1: introductionthe early history of cancer immunotherapycytokines as immunomodulatory drugs ...

Allergic Rhinitis Drugs Market Forecast 2014-2024: Future Prospects for Companies in Antihistamines, Corticosteroids, Immunotherapy & Vaccines

Allergic Rhinitis Drugs Market Forecast 2014-2024: Future Prospects for Companies in Antihistamines, Corticosteroids, Immunotherapy & Vaccines

  • $ 3 013
  • Industry report
  • August 2014
  • by Visiongain

... Market: trends and developments4.5.2.1 Cedar reforestation and the hay fever epidemic4.5.2.2 Generic penetration to reach 60% by 2018 4.5.2.3 Genetically modified rice as immunotherapy4 ...

Immunovative Therapies, Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Immunovative Therapies, Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2014
  • by Global Data

... immunotherapy drug products for treatment of cancer and infectious disease. It offers products that include allovax, allostim, cryostim, indications and animations. Itl develops products based on mirror effect ...

Bellicum Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Bellicum Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2014
  • by Global Data

... Develops novel cellular immunotherapies for the treatment of cancer. The company is developing new modes of treatment that can be controlled precisely following their administration. It has two products ...

Immunomic Therapeutics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Immunomic Therapeutics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2014
  • by Global Data

... Vaccines to treat disease applications in human and animal health. Its vaccines include ara-lamp-vax, multi-lamp-vax, jrc-lamp-vax, hiv-lamp-vax, and grnvac1/2 cancer immunotherapy. The company develops ...

About 600 reports for Immunotherapy

Download Unlimited Documents from Trusted Public Sources

Alk - Annual Report, June 2014

  • Alk Releases its Annual Report 2013
  • June 2014
    73 pages
  • Denmark  

    Europe  

View report >

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.